Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism AR degraders(Androgen Receptor degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H45ClN8O5 |
InChIKeyFQORVXSGECHHTM-LZZSZUQBSA-N |
CAS Registry2632306-29-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Prostate Carcinoma | Preclinical | US | Oncopia Therapeutics, Inc.Startup | 29 Jun 2023 |
Advanced Prostate Carcinoma | Preclinical | US | 29 Jun 2023 |